nvo stock price target tomorrow ?

The circled area highlights a significant upward movement in the stock price, with a sharp increase in the green candlestick, indicating strong buying sentiment. This could be due to positive news or favorable market conditions. The stock with this pattern is Novo Nordisk (NVO).

1. **Recent Price Target Adjustments**: BMO Capital lowered its price target on Novo Nordisk from $64.00 to $55.00 due to competitive pressure and shifting dynamics in the incretin drug market. Despite this, Novo Nordisk appears undervalued based on its Fair Value model.
2. **Analyst Ratings and Price Targets**: The average price target for Novo Nordisk (NVO) is $81.33, with a high forecast of $90.00 and a low forecast of $64.00, based on the consensus of four Wall Street analysts.
3. **Market Performance and Outlook**: Novo Nordisk's stock has experienced a significant decline of 36.54% year-to-date, but Deutsche Bank has reiterated its Buy rating, maintaining a positive outlook ahead of the company’s upcoming second-quarter earnings report.

Considering these factors, the stock may experience a rebound tomorrow. However, it's important to note that investing always carries risks, and investors should conduct their own research and consider their risk tolerance before making investment decisions.